Form 4/A for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2025-01-30 00:00:00 ET · period of report 2024-03-25 · accession 0001628280-25-003183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-01-30 | 2024-03-25 | CPIX | Krogulski Kenneth | Dir | A - Grant | $1.71 | +6,500 | 277.8K | +2% | +$11.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-25 | A | A | 6,500 | $1.71 | 277,843 | D | — | — | (F1) This amendment is being filed solely to correct an administrative error in reporting the number of Securities Acquired by Reporting Owner on the original Form 4 submitted on March 26, 2024, which were reported as 1,000 shares granted on March 25, 2024, but should have been reported as 2,500 shares. This reflects an increase of 1,500 shares. |